NOT:ETR
Novartis
144,82 €
arrow_downward
−0,41%(−0,60) 1D
13. stu, 17:35:38 GMT+1 · EUR
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za NOT...
Otvori
145,04 €
Najviša
145,56 €
Najniža
144,48 €
Trž. kap.
327,55 mlr.
Prosj. kol.
5,35 tis.
Količina
2,81 tis.
52-tjed. najviša
147,88 €
52-tjed. najniža
107,00 €
Broj djelatnika
75 tis.
Otvori
145,04 €
Najviša
145,56 €
Najniža
144,48 €
Trž. kap.
327,55 mlr.
Prosj. kol.
5,35 tis.
Količina
2,81 tis.
52-tjed. najviša
147,88 €
52-tjed. najniža
107,00 €
Broj djelatnika
75 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
Yahoo Finance
·
prije 3 sata
Novartis receives positive CHMP opinion for Cosentyx® in adolescents aged 12+ with hidradenitis suppurativa (HS)
Yahoo Finance
·
prije 1 dan
New long-term Rhapsido® (remibrutinib) Phase III data show sustained efficacy through week 52 in chronic inducible urticaria (CIndU)
Investor's Business Daily
·
prije 2 dana
How Amgen, In A Buy Zone, Is Taking On Novartis With A First-Ever
Investor's Business Daily
·
prije 3 dana
How Stock Of The Day TG Therapeutics Is Making Waves For Its Rivals
Profil
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Novartis – informacije
Glavni izvršni direktorVasant Narasimhan
Zaposlenici75,3 tis.
Osnovano7. ožu 1996.
SjedišteBasel, Basel-grad, Švicarska
SektorHealth Care
Djelatnost-
Web-lokacijanovartis.com